M-tron Industries, Inc. Stock Compensation Disclosure
In connection with the Separation, the Company's board of directors (the "Board") approved the Amended and Restated 2022 Incentive Plan (the "2022 Plan"), including the authority to issue 500,000 shares of common stock pursuant to the 2022 Plan. The 2022 Plan is the only long-term plan under which equity compensation may be awarded to employees, advisors and members of the Board aligning their interest with those of stockholders. As of December 31, 2024, 255,230 shares remained available for future issuance under the 2022 Plan.
The following table summarizes stock-based compensation expense, which includes expenses related to awards granted under the Plan for the period indicated:
| Year Ended December 31, | ||||||||
| (in thousands, except share data) | 2024 | 2023 | ||||||
| Restricted stock awards | $ | 636 | $ | 409 | ||||
| Stock options | — | 2,013 | ||||||
| Total | $ | 636 | $ | 2,422 | ||||
Restricted Stock Awards
Restricted stock awards are measured at a value equal to the market price of the Company's common stock on the date of grant which is recognized over the service period of the award.
A summary of the Company's restricted stock awards for the year ended December 31, 2024 follows:
| (in thousands, except share data) | Number of Shares | Weighted Average Grant Date Fair Value | Aggregate Grant Date Fair value | |||||||||
| Balance as of December 31, 2023 | 79,896 | $ | 11.20 | $ | 895 | |||||||
| Granted | 32,548 | 38.66 | 1,258 | |||||||||
| Vested | (42,320 | ) | (12.93 | ) | (547 | ) | ||||||
| Balance as of December 31, 2024 | 70,124 | $ | 22.90 | $ | 1,606 | |||||||
As of December 31, 2024, there was $1,371 of total unrecognized compensation cost related to nonvested shares granted. The cost is expected to be recognized over a weighted-average period of 1.9 years.
Stock Options
The following table provides a rollforward of stock option activity:
| (in thousands, except share data) | Number of Options Outstanding | Weighted Average Exercise Price | Weighted Average Grant Date Fair Value | Weighted Average Remaining Term (in years) | Aggregate Intrinsic Value | |||||||||||||||
| Outstanding and exercisable as of December 31, 2023 | 193,010 | $ | 34.90 | $ | 10.63 | 2.9 | $ | 219 | ||||||||||||
| Granted | — | — | — | |||||||||||||||||
| Exercised | (92,296 | ) | (33.64 | ) | (10.05 | ) | ||||||||||||||
| Forfeited | (2,700 | ) | (36.06 | ) | (10.98 | ) | ||||||||||||||
| Outstanding and exercisable as of December 31, 2024 | 98,014 | $ | 36.06 | $ | 10.98 | 2.0 | $ | 1,212 | ||||||||||||
About Stock Compensation Disclosures
Stock-based compensation disclosures detail the equity awards granted to employees and executives — including stock options, restricted stock units (RSUs), and performance shares — along with the valuation methods and assumptions used to expense them. This section reveals the true cost of talent retention and the alignment between management incentives and shareholder interests.
Key signals: total unrecognized compensation expense and its expected recognition period signal future earnings headwinds from already-granted awards. For stock options, examine Black-Scholes assumptions — expected volatility, risk-free rate, and expected term — as understating any of these reduces reported compensation expense. Compare stock compensation expense as a percentage of revenue against peers to assess dilution cost. Watch vesting schedules for acceleration clauses tied to change-of-control events. Performance-based awards with undemanding targets may indicate weak governance. Add back stock compensation to operating cash flow to calculate a more conservative free cash flow figure.